|
시장보고서
상품코드
1504966
암치료용 임상 영양 시장, 점유율, 규모, 동향, 산업 분석 리포트 : 유형별, 암 유형별, 연령층별, 판매채널별, 지역별, 부문별 예측(2024-2032년)Clinical Nutrition for Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Type; By Cancer Type; By Age Group; By Sales Channel, By Region; Segment Forecast, 2024- 2032 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면 세계의 암치료용 임상 영양 시장 규모는 2032년까지 71억 1,000만 달러에 달할 전망입니다. 현재 시장 역학에 대한 상세 인사이트를 제시하고, 향후 시장 성장에 관한 분석을 제공하고 있습니다.
암 환자의 면역력을 향상시키기 위해 필요한 영양소를 공급할 수 있는 영양 보조 제품의 능력이 시장 성장의 주요 원인으로 작용하고 있습니다. 또한 신제품 출시, 합병, 인수, 제휴, 파트너십 등 전략적 구상의 실행이 시장 성장에 기여하고 있습니다. 예를 들어 2024년 1월 다논 뉴트리시아(Danone Nutricia)는 암 환자를 위한 영양 지원 모듈을 개발하기 위해 레질리언스(Resilience)와의 새로운 제휴를 발표했습니다. 이러한 전략적 노력으로 향후 수년간 영양은 암 치료의 필수적인 부분이 될 것으로 보입니다.
좌식 생활, 운동 부족, 유전은 암의 주요 원인 중 일부입니다. 암 질환의 유병률 증가, 암 환자의 영양실조 발생률 증가, 암 치료 센터 인프라 개선, 다양한 유형의 암 치료를 위한 입원 환자 수 증가는 암치료용 임상 영양 시장의 성장을 이끄는 주요 요인 중 일부입니다. 예를 들어 세계보건기구(WHO)가 발표한 통계에 따르면 2022년에는 전 세계 115개국에서 2,000만 명의 신규 암 환자가 발생할 것으로 추정됩니다.
맞춤형 치료에 대한 높은 수요, 암 치료 중 영양 상태를 평가할 필요성이 증가하고, 더 나은 치료 결과를 초래하는 효과적인 영양 보충제의 출현은 예측 기간 중 시장에 기여할 것으로 예상됩니다. 또한 면역 종양학 치료를 받고 있는 암 환자의 면역 체계를 교정해야 할 필요성이 암용 영양 보충제에 대한 수요를 증가시킬 것으로 예상됩니다. 또한 보완적 치료법으로서 암 영양에 대한 의료진 교육에 대한 제조업체의 관심이 높아짐에 따라 향후 수년간 시장 성장에 도움이 될 것으로 예상됩니다.
암치료용 임상 영양 시장 보고서 - 하이라이트
경구용 영양제 분야는 암 환자들에게 제공하는 섭취의 용이성, 편의성 등의 장점으로 인해 시장을 독점하고 있습니다.
폐암 분야는 선진국의 높은 폐암 유병률로 인해 높은 CAGR로 확대될 것으로 예상됩니다.
성인 암 환자의 영양실조 발생률이 증가함에 따라 2023년에는 성인 시장이 세계 시장을 장악했습니다.
온라인 판매에 대한 선호도가 높아짐에 따라 온라인 부문이 가장 높은 CAGR을 나타낼 것으로 예상됩니다.
북미가 가장 큰 시장 점유율을 차지한 것은 암 환자의 높은 유병률과 암 치료 전 영양 상태 평가에 대한 요구가 높아졌기 때문으로 분석됩니다.
시장 참여 기업에는 Nestle Health Science, Abbott Nutrition, Danone Nutricia, Bayer AG, Baxter 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 암치료용 임상 영양 시장 인사이트
- 암치료용 임상 영양학 - 업계 스냅숏
- 암치료용 임상 영양 시장 역학
- 촉진요인과 기회
- 암환자의 암부담 증가와 영양실조 리스크의 상승이 시장의 성장을 촉진하고 있다.
- 암치료에서 영양의 잠재적 이점은 시장 성장에 유익하다는 것이 증명된다.
- 억제요인과 과제
- 종양 영양학에서 임상적 증거의 결여에 의해 암치료용 임상 영양 시장의 확대가 제한되고 있다.
- 촉진요인과 기회
- PESTLE 분석
- 암치료에서 임상 영양 업계 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 암치료용 임상 영양 시장 : 유형별
- 주요 조사 결과
- 서론
- 경구 영양
- 경장영양
- 경장영양제
제6장 세계의 암치료용 임상 영양 시장 : 암 유형별
- 주요 조사 결과
- 서론
- 두경부암
- 위암 및 소화기 암
- 혈액암
- 유방암
- 폐암
- 기타
제7장 세계의 암치료용 임상 영양 시장 : 연령층별
- 주요 조사 결과
- 서론
- 성인
- 소아
제8장 세계의 암치료용 임상 영양 시장 : 판매채널별
- 주요 조사 결과
- 서론
- 오프라인
- 온라인
제9장 세계의 암치료용 임상 영양 시장 : 지역별
- 주요 조사 결과
- 서론
- 암치료용 임상 영양 시장 평가 : 지역,2019-2032년
- 북미
- 북미 : 유형별,2019-2032년
- 북미 : 판매채널별,2019-2032년
- 북미 : 암 유형별,2019-2032년
- 북미 : 연령별,2019-2032년
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별,2019-2032
- 유럽 : 판매채널별,2019-2032년
- 유럽 : 암 유형별,2019-2032년
- 유럽 : 연령별,2019-2032년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 아시아태평양
- 아시아태평양 : 유형별,2019-2032
- 아시아태평양 : 판매채널별,2019-2032년
- 아시아태평양 : 암 유형별,2019-2032년
- 아시아태평양 : 연령별,2019-2032년
- 중국
- 인도
- 일본
- 말레이시아
- 인도네시아
- 한국
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별,2019-2032년
- 중동 및 아프리카 : 판매채널별,2019-2032년
- 중동 및 아프리카 : 암 유형별,2019-2032년
- 중동 및 아프리카 : 연령별,2019-2032년
- 사우디아라비아
- 남아프리카공화국
- 이스라엘
- 아랍에미리트
- 라틴아메리카
- 라틴아메리카 : 유형별,2019-2032년
- 라틴아메리카 : 판매채널별,2019-2032년
- 라틴아메리카 : 암 유형별,2019-2032년
- 라틴아메리카 : 연령별,2019-2032년
- 멕시코
- 브라질
- 아르헨티나
제10장 경쟁 구도
- 확대와 인수의 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 개요
- Abbott Nutrition(U.S.)
- Baxter(U.S.)
- Bayer AG(Germany)
- Danone Nutricia(The Netherlands)
- GlaxoSmithKline plc(UK)
- Medtrition, Inc.(U.S.)
- Nestle Health Science(Switzerland)
- Otsuka Holdings Co., Ltd.(Japan)
- Pfizer Inc.(U.S.)
- Victus, Inc.(U.S.)
The global clinical nutrition for cancer care market size is expected to reach USD 7.11 billion by 2032, according to a new study by Polaris Market Research. The report "Clinical Nutrition for Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Type (Oral Nutrition, Parenteral Nutrition, and Enteral Feeding Formulas); By Cancer Type; By Age Group; By Sales Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The ability of nutritional support products to improve the immunity of cancer patients by providing the required amount of nutrients is primarily responsible for the market growth. Moreover, the implementation of strategic initiatives such as new product launches, merges, acquisitions, alliance, and partnerships contribute to the market growth. For instance, in January 2024, Danone Nutricia announced a new partnership with Resilience to develop nutritional support module for patients with cancer. Such strategic initiatives will make nutrition an integral part of oncology treatment in the coming years.
Sedentary lifestyle, lack of physical activity, and inheritance are some of main causes of cancer. Growing prevalence of cancer disease, increasing incidence of malnourishment among cancer patients, improving infrastructure of cancer care centers, and rising hospital admissions for the treatment of various types of cancer are some of the major factors responsible for the growth of clinical nutrition for cancer care market. For instance, according as per the fact & figures published by the World Health Organization (WHO), in 2022, an estimated 20 million new cancer cases were reported in 115 countries across the world.
High demand for personalized treatment, rising need to assess nutritional status during cancer therapy, and the advent of effective nutritional supplements with better treatment outcomes are expected to contribute to the market during the forecast period. Moreover, the necessity to modify the immune system among the cancer patients receiving immune-oncology treatment will increase the demand for nutritional supplements for cancer. Furthermore, rising focus of manufacturers towards educating healthcare practitioners on cancer nutrition as a complementary treatment will boost the market growth in the upcoming years.
Clinical Nutrition for Cancer Care Market Report Highlights
The oral nutrition segment dominated the market, owing to the benefits such as ease of consumption and convenience offered by oral supplements to cancer patients.
The lung cancer segment is expected to expand at the significant CAGR, owing to the high prevalence of lung cancer in the developed countries.
The adults segment dominated the global market in 2023, owing to increasing occurrence rate of malnourishment among adult cancer patients.
The online segment is anticipated to register the highest CAGR, owing to the increasing preference to online distribution.
North America held the largest market share, owing to the high prevalence of cancer patients and rising need for assessment of nutritional status before cancer therapy.
The market players include Nestle Health Science, Abbott Nutrition, Danone Nutricia, Bayer AG, and Baxter among others.
Polaris Market Research has segmented the clinical nutrition for cancer care market report based on and region:
Clinical Nutrition for Cancer Care, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Oral Nutrition
- Parenteral Nutrition
- Enteral Feeding Formulas
Clinical Nutrition for Cancer Care, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Head & Neck Cancer
- Stomach & Gastrointestinal Cancers
- Blood Cancer
- Breast Cancer
- Lung Cancer
- Others
Clinical Nutrition for Cancer Care, Age Group Outlook (Revenue - USD Billion, 2019 - 2032)
- Adult
- Pediatric
Clinical Nutrition for Cancer Care, Sales Channel Outlook (Revenue - USD Billion, 2019 - 2032)
- Offline
- Online
Clinical Nutrition for Cancer Care, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Clinical Nutrition for Cancer Care Market Insights
- 4.1. Clinical Nutrition for Cancer Care - Industry Snapshot
- 4.2. Clinical Nutrition for Cancer Care Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing cancer burden and rising risk of malnutrition in oncology patients are driving the market growth
- 4.2.1.2. Potential benefits of nutrition in cancer treatment will prove beneficial for the market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of clinical evidence in oncology nutrition limits the expansion of clinical nutrition for cancer care market
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Clinical Nutrition for Cancer Care Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Clinical Nutrition for Cancer Care Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 5.3. Oral Nutrition
- 5.3.1. Global Clinical Nutrition for Cancer Care Market, by Oral Nutrition, by Region, 2019-2032 (USD Billion)
- 5.4. Parenteral Nutrition
- 5.4.1. Global Clinical Nutrition for Cancer Care Market, by Parenteral Nutrition, by Region, 2019-2032 (USD Billion)
- 5.5. Enteral Feeding Formulas
- 5.5.1. Global Clinical Nutrition for Cancer Care Market, by Enteral Feeding Formulas, by Region, 2019-2032 (USD Billion)
6. Global Clinical Nutrition for Cancer Care Market, by Cancer Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 6.3. Head & Neck Cancer
- 6.3.1. Global Clinical Nutrition for Cancer Care Market, by Head & Neck Cancer, by Region, 2019-2032 (USD Billion)
- 6.4. Stomach & Gastrointestinal Cancers
- 6.4.1. Global Clinical Nutrition for Cancer Care Market, by Stomach & Gastrointestinal Cancers, by Region, 2019-2032 (USD Billion)
- 6.5. Blood Cancer
- 6.5.1. Global Clinical Nutrition for Cancer Care Market, by Blood Cancer, by Region, 2019-2032 (USD Billion)
- 6.6. Breast Cancer
- 6.6.1. Global Clinical Nutrition for Cancer Care Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
- 6.7. Lung Cancer
- 6.7.1. Global Clinical Nutrition for Cancer Care Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
- 6.8. Others
- 6.8.1. Global Clinical Nutrition for Cancer Care Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Clinical Nutrition for Cancer Care Market, by Age Group
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 7.3. Adult
- 7.3.1. Global Clinical Nutrition for Cancer Care Market, by Adult, by Region, 2019-2032 (USD Billion)
- 7.4. Paediatric
- 7.4.1. Global Clinical Nutrition for Cancer Care Market, by Paediatric, by Region, 2019-2032 (USD Billion)
8. Global Clinical Nutrition for Cancer Care Market, by Sales Channel
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 8.3. Offline
- 8.3.1. Global Clinical Nutrition for Cancer Care Market, by Offline, by Region, 2019-2032 (USD Billion)
- 8.4. Online
- 8.4.1. Global Clinical Nutrition for Cancer Care Market, by Online, by Region, 2019-2032 (USD Billion)
9. Global Clinical Nutrition for Cancer Care Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Clinical Nutrition for Cancer Care Market Assessment, By Geography, 2019-2032 (USD Billion)
- 9.3. Clinical Nutrition for Cancer Care Market - North America
- 9.3.1. North America: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.3.2. North America: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.3.3. North America: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.3.4. North America: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.3.5. Clinical Nutrition for Cancer Care Market - U.S.
- 9.3.5.1. U.S.: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.3.5.2. U.S.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.3.5.3. U.S.: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.3.5.4. U.S.: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.3.6. Clinical Nutrition for Cancer Care Market - Canada
- 9.3.6.1. Canada: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.3.6.2. Canada: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.3.6.3. Canada: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.3.6.4. Canada: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4. Clinical Nutrition for Cancer Care Market - Europe
- 9.4.1. Europe: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.2. Europe: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.3. Europe: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.4. Europe: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.5. Clinical Nutrition for Cancer Care Market - UK
- 9.4.5.1. UK: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.5.2. UK: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.5.3. UK: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.5.4. UK: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.6. Clinical Nutrition for Cancer Care Market - France
- 9.4.6.1. France: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.6.2. France: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.6.3. France: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.6.4. France: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.7. Clinical Nutrition for Cancer Care Market - Germany
- 9.4.7.1. Germany: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.7.2. Germany: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.7.3. Germany: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.7.4. Germany: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.8. Clinical Nutrition for Cancer Care Market - Italy
- 9.4.8.1. Italy: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.8.2. Italy: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.8.3. Italy: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.8.4. Italy: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.9. Clinical Nutrition for Cancer Care Market - Spain
- 9.4.9.1. Spain: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.9.2. Spain: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.9.3. Spain: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.9.4. Spain: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.10. Clinical Nutrition for Cancer Care Market - Netherlands
- 9.4.10.1. Netherlands: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.10.2. Netherlands: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.10.3. Netherlands: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.10.4. Netherlands: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.4.11. Clinical Nutrition for Cancer Care Market - Russia
- 9.4.11.1. Russia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.4.11.2. Russia.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.4.11.3. Russia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.4.11.4. Russia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5. Clinical Nutrition for Cancer Care Market - Asia Pacific
- 9.5.1. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.5. Clinical Nutrition for Cancer Care Market - China
- 9.5.5.1. China: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.5.2. China.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.5.3. China: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.5.4. China: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.6. Clinical Nutrition for Cancer Care Market - India
- 9.5.6.1. India: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.6.2. India.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.6.3. India: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.6.4. India: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.7. Clinical Nutrition for Cancer Care Market - Japan
- 9.5.7.1. Japan: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.7.2. Japan.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.7.3. Japan: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.7.4. Japan: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.8. Clinical Nutrition for Cancer Care Market - Malaysia
- 9.5.8.1. Malaysia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.8.2. Malaysia.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.8.3. Malaysia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.8.4. Malaysia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.9. Clinical Nutrition for Cancer Care Market - Indonesia
- 9.5.9.1. Indonesia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.9.2. Indonesia.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.9.3. Indonesia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.9.4. Indonesia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.5.10. Clinical Nutrition for Cancer Care Market - South Korea
- 9.5.10.1. South Korea: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.5.10.2. South Korea.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.5.10.3. South Korea: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.5.10.4. South Korea: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6. Clinical Nutrition for Cancer Care Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.5. Clinical Nutrition for Cancer Care Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.5.2. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.5.3. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.5.4. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.6. Clinical Nutrition for Cancer Care Market - South Africa
- 9.6.6.1. South Africa: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.6.2. South Africa: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.6.3. South Africa: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.6.4. South Africa: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.7. Clinical Nutrition for Cancer Care Market - Israel
- 9.6.7.1. Israel: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.7.2. Israel: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.7.3. Israel: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.7.4. Israel: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.6.8. Clinical Nutrition for Cancer Care Market - UAE
- 9.6.8.1. UAE: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.6.8.2. UAE: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.6.8.3. UAE: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.6.8.4. UAE: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.7. Clinical Nutrition for Cancer Care Market - Latin America
- 9.7.1. Latin America: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.7.5. Clinical Nutrition for Cancer Care Market - Mexico
- 9.7.5.1. Mexico: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.7.5.2. Mexico: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.7.5.3. Mexico: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.7.5.4. Mexico: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.7.6. Clinical Nutrition for Cancer Care Market - Brazil
- 9.7.6.1. Brazil: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.7.6.2. Brazil: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.7.6.3. Brazil: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.7.6.4. Brazil: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
- 9.7.7. Clinical Nutrition for Cancer Care Market - Argentina
- 9.7.7.1. Argentina: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
- 9.7.7.2. Argentina: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
- 9.7.7.3. Argentina: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
- 9.7.7.4. Argentina: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abbott Nutrition (U.S.)
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Baxter (U.S.)
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Bayer AG (Germany)
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Danone Nutricia (The Netherlands)
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. GlaxoSmithKline plc (UK)
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Medtrition, Inc. (U.S.)
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Nestle Health Science (Switzerland)
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Otsuka Holdings Co., Ltd. (Japan)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Pfizer Inc. (U.S.)
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Victus, Inc. (U.S.)
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
비교리스트